CELL & GENE THERAPY INSIGHTS

Spotlight

Supply Chain FOCUS

Interview


On Demand Webinar

Importance of high-quality starting material for success in advanced therapy

Bob Amareld,
Nathan Frank, MS,
Jason C Lin,
Richard McFarland,
John Paul Tomtishen III
12 August 2021
On Demand Webinar

Report

Other articles

Innovator Insight

When using a closed and automated manufacturing platform, is there an option to maintain flexibility?

Kaman Kim,
Carlos Yuraszeck,
Joseph O’Connor
12 August 2021
Innovator Insight

Webinars

Delivering an end-to-end industrialization roadmap for autologous cell therapy

Delivering an end-to-end industrialization roadmap for autologous cell therapy

Matt Hewitt, PhD
Matt Hewitt, PhD, Senior Director, Scientific Services, Cell and Gene Therapy, Charles River Laboratories
Joe Garrity
Joe Garrity, Head of Autologous Cell Therapy Commercial Development, CGT, Lonza
Walter Bagni
Walter Bagni, Cell & Gene Technologies & Labelling CoE Lead, Lonza
6 July 2021
Webinar
Assuring manufacturing and data integrity for cell and gene therapy regulatory compliance

Assuring manufacturing and data integrity for cell and gene therapy regulatory compliance

Jelena Jurlin
Jelena Jurlin, Head of Compliance, Lonza
Dr. Dmitry Fridman
Dr. Dmitry Fridman, Global Product Manager, Miltenyi Biotec B.V. & Co. KG
14 July 2021
Webinar
Expression systems for viral vector production: advantages of the Sf9 Baculovirus system and simple solutions to address its specific analytical challenges

Expression systems for viral vector production: advantages of the Sf9 Baculovirus system and simple solutions to address its specific analytical challenges

Yi Fang Lee
Yi Fang Lee, R&D Scientist, Thermo Fisher Scientific
Srinath Kashi Ranganath
Srinath Kashi Ranganath, Staff Scientist – Field Applications, Thermo Fisher Scientific
22 July 2021
Webinar